FDA Soon to Issue Drug Shortage Notification Rule

The Food and Drug Administration is poised to publish a proposed rule to require notification from drug manufacturers of discontinuances or interruptions in the manufacturing of life-supporting and certain other important drugs.

Get access to this article and thousands more...

All Health Data Management articles are archived after 7 days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, podcasts, e-books, and conference discounts. Qualified members may also choose to receive our free monthly magazine and any of our e-newsletters covering the latest breaking news, opinions from industry leaders, developing trends and specialized topics like EHR's, revenue cycle management, health insurance exchanges, analytics, and more!

Already Registered?

Forgot Password/Need Help?
Comments (1)
This is a bad news for those people consuming drugs for medication because it'll be hard for them to buy medicine if the one they are trying to purchase belongs to those drugs having short supply. One of the most important medication shortages is that of Adderall, a popular medication for treating ADHD. For more information, rel='nofollow' href="https://www.matchfinancial.com/application/">click here.
Posted by Erica H | Sunday, July 27 2014 at 2:26AM ET
Add Your Comments:
Not Registered?
You must be registered to post a comment. Click here to register.
Already registered? Log in here
Please note you must now log in with your email address and password.


Slide Shows

Already a subscriber? Log in here
Please note you must now log in with your email address and password.